SARS-CoV-2

Suman Pradhan1, Susan D Rouster2, Jason T Blackard2

  • 1Department of Molecular and Cellular Biosciences, University of Cincinnati College of Medicine, Cincinnati, Ohio.

Pathogens & immunity
|February 16, 2024
PubMed
概括

SARS-CoV-2 在肝细胞中活跃复制,通过亡导致细胞死亡. 抗病毒药物remdesivir有效地阻止了这种病毒复制和肝损伤,这表明活跃复制有助于COVID-19中的肝功能障碍.